Literature DB >> 8382801

Characterization of an altered DNA catalysis of a camptothecin-resistant eukaryotic topoisomerase I.

I I Gromova1, E Kjeldsen, J Q Svejstrup, J Alsner, K Christiansen, O Westergaard.   

Abstract

We investigated topoisomerase I activity at a specific camptothecin-enhanced cleavage site by use of a partly double-stranded DNA substrate. The cleavage site belongs to a group of DNA topoisomerase I sites which is only efficiently cleaved by wild-type topoisomerase I (topo I-wt) in the presence of camptothecin. With a mutated camptothecin-resistant form of topoisomerase I (topo I-K5) previous attempts to reveal cleavage activity at this site have failed. On this basis it was questioned whether the mutant enzyme has an altered DNA sequence recognition or a changed rate of catalysis at the site. Utilizing a newly developed assay system we demonstrate that topo I-K5 not only recognizes and binds to the strongly camptothecin-enhanced cleavage site but also has considerable cleavage/religation activity at this particular DNA site. Thus, topo I-K5 has a 10-fold higher rate of catalysis and a 10-fold higher affinity for DNA relative to topo I-wt. Our data indicate that the higher cleavage/religation activity of topo I-K5 is a result of improved DNA binding and a concomitant shift in the equilibrium between cleavage and religation towards the religation step. Thus, a recently identified point mutation which characterizes the camptothecin-resistant topo I-K5 has altered the enzymatic catalysis without disturbing the DNA sequence specificity of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382801      PMCID: PMC309157          DOI: 10.1093/nar/21.3.593

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  Topoisomerase I has a strong binding preference for a conserved hexadecameric sequence in the promoter region of the rRNA gene from Tetrahymena pyriformis.

Authors:  A H Andersen; E Gocke; B J Bonven; O F Nielsen; O Westergaard
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

Review 2.  DNA topoisomerases: enzymes that control DNA conformation.

Authors:  H P Vosberg
Journal:  Curr Top Microbiol Immunol       Date:  1985       Impact factor: 4.291

Review 3.  DNA topoisomerases.

Authors:  J C Wang
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

4.  New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site.

Authors:  J Q Svejstrup; K Christiansen; I I Gromova; A H Andersen; O Westergaard
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

5.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Recognition sites of eukaryotic DNA topoisomerase I: DNA nucleotide sequencing analysis of topo I cleavage sites on SV40 DNA.

Authors:  K A Edwards; B D Halligan; J L Davis; N L Nivera; L F Liu
Journal:  Nucleic Acids Res       Date:  1982-04-24       Impact factor: 16.971

8.  Nucleotide sequence preference at rat liver and wheat germ type 1 DNA topoisomerase breakage sites in duplex SV40 DNA.

Authors:  M D Been; R R Burgess; J J Champoux
Journal:  Nucleic Acids Res       Date:  1984-04-11       Impact factor: 16.971

9.  Rapid purification and characterization of DNA topoisomerase I from cultured mouse mammary carcinoma FM3A cells.

Authors:  K Ishii; T Hasegawa; K Fujisawa; T Andoh
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

10.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

View more
  8 in total

1.  Position-specific trapping of topoisomerase I-DNA cleavage complexes by intercalated benzo[a]- pyrene diol epoxide adducts at the 6-amino group of adenine.

Authors:  Y Pommier; G S Laco; G Kohlhagen; J M Sayer; H Kroth; D M Jerina
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 2.  Topoisomerase I in multiple drug resistance.

Authors:  A Pessina
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

3.  Inhibition of DNA topoisomerase I activity by heparan sulfate and modulation by basic fibroblast growth factor.

Authors:  I Kovalszky; J Dudás; J Oláh-Nagy; G Pogány; J Töváry; J Timár; L Kopper; A Jeney; R V Iozzo
Journal:  Mol Cell Biochem       Date:  1998-06       Impact factor: 3.396

4.  Topoisomerase I inhibitors and drug resistance.

Authors:  R E Parchment; A Pessina
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

5.  Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines.

Authors:  U Vanhoefer; M R Müller; R A Hilger; B Lindtner; U Klaassen; N Schleucher; Y M Rustum; S Seeber; A Harstrick
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

6.  Topoisomerase I as a biomarker: detection of activity at the single molecule level.

Authors:  Joanna Proszek; Amit Roy; Ann-Katrine Jakobsen; Rikke Frøhlich; Birgitta R Knudsen; Magnus Stougaard
Journal:  Sensors (Basel)       Date:  2014-01-10       Impact factor: 3.576

7.  Novel bivalent securinine mimetics as topoisomerase I inhibitors.

Authors:  Wen Hou; Hui Lin; Zhen-Ya Wang; Martin G Banwell; Ting Zeng; Ping-Hua Sun; Jing Lin; Wei-Min Chen
Journal:  Medchemcomm       Date:  2017-01-03       Impact factor: 3.597

8.  The Aza-Analogous Benzo[c]phenanthridine P8-D6 Acts as a Dual Topoisomerase I and II Poison, thus Exhibiting Potent Genotoxic Properties.

Authors:  Georg Aichinger; Falk-Bach Lichtenberger; Tamara N Steinhauer; Inken Flörkemeier; Giorgia Del Favero; Bernd Clement; Doris Marko
Journal:  Molecules       Date:  2020-03-27       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.